DrugPatentWatch Database Preview
« Back to Dashboard
Signifor Lar is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are four patents protecting this drug.
The generic ingredient in SIGNIFOR LAR is pasireotide pamoate. One supplier is listed for this compound. Additional details are available on the pasireotide pamoate profile page.
Generic Entry Opportunity Date for SIGNIFOR LAR
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.